Moderna, Inc. Form 8-K Summary
Business Context and Reporting Period
This filing is a Current Report (Form 8-K) dated June 27, 2019, regarding the results of Moderna, Inc.'s 2019 Annual Meeting of Stockholders. The meeting was held on the same date with a quorum present.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The filing reports the final voting outcomes for two proposals:
- Proposal 1: Election of Directors
- Noubar Afeyan, Ph.D.: 246,605,384 For; 3,527,571 Withheld; 5,359,484 Broker Non-Votes.
- Stéphane Bancel: 247,204,447 For; 2,928,508 Withheld; 5,359,484 Broker Non-Votes.
- Peter Barton Hutt, LL.M.: 233,850,613 For; 16,282,342 Withheld; 5,359,484 Broker Non-Votes.
- All three individuals were elected as Class I directors for a three-year term expiring at the 2022 Annual Meeting.
- Proposal 2: Ratification of Auditors
- Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2019.
- Votes: 254,629,887 For; 819,203 Against; 43,349 Abstaining.
- There were no broker non-votes on this proposal.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation that the three Class I directors were successfully elected for a term ending in 2022.
- Verification that Ernst & Young LLP was ratified as the auditor for the 2019 fiscal year.
- Review of the significant number of broker non-votes (5,359,484) recorded for the director elections.
